How do LVAD nurses explain to a Spanish-speaking patient why she needs a mechanical pump when her heart is still beating?

The question “pero si el corazón todavía late — ¿para qué necesito una bomba?” is the central communication failure in the pre-LVAD conversation. The patient knows her heart is beating. She can feel it. She cannot understand how a beating heart can be so insufficient that a machine must be added. The LVAD nurse needs to give her the framework in three steps. First, what the ejection fraction number means in terms of flow: a normal heart ejects 55 to 70 percent of the blood in the left ventricle with each beat. An ejection fraction of 15 percent means the heart is ejecting only 15 of every 100 milliliters in the ventricle and leaving 85 behind. The heart beats, but each beat produces only a fraction of the forward flow the body requires. Second, what happens to the 85 percent that is not ejected: it accumulates in the left ventricle, raises left ventricular end-diastolic pressure, and forces that pressure backward through the mitral valve into the left atrium and then into the pulmonary veins and the lung capillaries. Pulmonary capillary pressures above 18 to 25 mmHg force fluid out of the capillaries and into the alveolar spaces — pulmonary edema. At the same time, the forward flow that does reach the aorta is insufficient for the kidneys, the liver, the brain, and the muscles: fatigue, decreased urine output, mental fog, rising creatinine. Third, what the LVAD does: the inflow cannula sits in the apex of the left ventricle and actively pulls blood out of the ventricle; the outflow cannula delivers it directly into the ascending aorta. The pump spins continuously at 2,400 to 3,200 rotations per minute, generating a flow of four to six liters per minute regardless of what the native heart contributes. The left ventricle decompresses — the blood that was accumulating is now being removed. Pulmonary pressures fall. Renal and hepatic perfusion improve. The native heart still beats and contributes whatever it can, but it is no longer the only mechanism generating forward flow. In Spanish: “El corazón sí late, pero con cada latido sólo está empujando el 15 por ciento de la sangre que hay adentro. El 85 por ciento que se queda va acumulando presión hacia atrás — eso es lo que está llenando los pulmones de líquido y lo que le está agotando los riñones. La bomba entra por la punta del corazón, saca la sangre que el corazón no puede sacar solo, y la lleva directo a la aorta. El corazón sigue latiendo y contribuye lo que puede. La bomba hace el resto.” (The heart is beating, but with each beat it is only pushing 15 percent of the blood inside. The 85 percent that stays accumulates pressure backward — that is what is filling the lungs with fluid and what is exhausting the kidneys. The pump enters through the tip of the heart, takes out the blood the heart cannot remove alone, and delivers it directly to the aorta. The heart keeps beating and contributes what it can. The pump does the rest.)

Why is LVAD driveline infection so dangerous and what should Spanish-speaking patients do if they notice redness or warmth at the exit site?

The LVAD driveline is a percutaneous cable that exits the skin in the abdomen and connects the internal pump to an external controller and battery system. It passes through the skin, through subcutaneous tissue, and into the mediastinal space where the pump sits. This creates a permanent anatomical pathway from the external environment to the mediastinum — a pathway that, once infected, can carry bacteria directly to the pump housing, the device pocket, and the surrounding cardiac structures. Driveline exit site infection is the most common LVAD-related complication and a leading source of LVAD-related morbidity and mortality. It occurs in 10 to 40 percent of patients over the device lifetime. Superficial infections — limited to the skin at the exit site — can be managed with oral antibiotics and intensified local care if caught early. But infection that ascends along the driveline into the subcutaneous tunnel, the device pocket, or the mediastinum requires intravenous antibiotics, surgical debridement, and in severe cases, device exchange or transplant as the only resolution. Mediastinitis and endocarditis from ascending driveline infection carry mortality rates of 20 to 50 percent in this patient population. Any sign of infection at the exit site — redness, warmth, swelling, induration, pain or tenderness, drainage (purulent or non-purulent), separation of the driveline from the surrounding skin, or new crusting — is a reason to call the LVAD clinic the same day, not to watch and wait. Topical over-the-counter antibiotics, including triple antibiotic ointment (Neosporin), should not be applied to the driveline exit site without explicit instruction from the LVAD team. Neomycin, one of the three components, is associated with contact dermatitis and skin sensitization, and unsupervised topical antibiotic application can alter the local skin flora in ways that promote resistant organisms and mask the true clinical picture. In Spanish: “El cable que sale de la piel tiene un camino que va directo al lugar donde está la bomba, dentro del pecho. Si la infección empieza en la piel y no se trata rápido, puede subir por ese camino hasta el corazón. Por eso cualquier enrojecimiento, calor, o pus en el sitio donde sale el cable — llame a la clínica el mismo día. No espere. No ponga cremas o antíbioticos sin hablarnos primero.” (The cable that exits the skin has a path that goes directly to where the pump is, inside the chest. If the infection starts in the skin and is not treated quickly, it can travel up that path to the heart. That is why any redness, warmth, or pus at the cable exit site — call the clinic the same day. Do not wait. Do not apply creams or antibiotics without talking to us first.)

How do LVAD nurses explain to a Spanish-speaking patient that an INR of 1.7 is dangerous even when she feels completely well?

The LVAD patient whose INR is subtherapeutic and who feels fine presents the classic high-stakes asymptomatic-risk communication problem: the danger is not visible, felt, or experienced in the moment, but the downstream consequence — pump thrombosis — is catastrophic and often occurs without warning. Continuous-flow LVADs generate non-pulsatile flow by spinning a rotor at 2,400 to 3,200 rotations per minute. The blood moves continuously through the pump housing and past the inflow and outflow cannulas. Any area of stasis, slow flow, or exposed prosthetic surface is a site of potential clot formation. The HeartMate 3 uses full magnetic levitation of the rotor, which reduces contact with the blood and lowers the thrombotic risk compared with older devices — but does not eliminate it. The target INR for most LVAD patients is 2.0 to 3.0. An INR of 1.7 is below this range: the blood is not anticoagulated to the level that prevents clot formation on the device surface. Pump thrombosis — thrombus forming within the pump — does not always produce immediate dramatic symptoms. The early signs are often indirect: rising lactate dehydrogenase (LDH) as the pump works harder and lyses more red blood cells; increased power consumption by the pump (visible on the pump log downloaded at clinic visits); reduced pump flow readings; new pulsatility index changes. The LVAD team detects these signals before the patient has symptoms. By the time the patient feels worse — shortness of breath returning, exercise tolerance dropping, the symptoms of pump failure — the thrombus is established and harder to treat. Medical thrombolysis (t-PA infusion) carries a significant bleeding risk and is not always successful. Surgical pump exchange carries the risks of redo cardiac surgery in a patient with advanced heart failure. The consequence is too large to wait for symptoms. In Spanish: “Usted no se siente diferente porque el corazón todavía está recibiendo apoyo de la bomba. El peligro no está en cómo se siente ahora mismo — está en lo que le puede pasar a la bomba si la sangre forma un coágulo adentro de ella. Cuando eso pasa, los primeros signos los vemos nosotros en los datos de la bomba, antes de que usted sienta algo. Si esperamos a que usted se sienta mal, ya es más difícil de tratar. El INR de 2.7 que tenía la última vez mantuvo la sangre lo suficientemente fluida para que la bomba funcionara sin problemas. El 1.7 de hoy no es suficiente. Necesitamos ajustar la dosis hoy.” (You do not feel different because the heart is still receiving support from the pump. The danger is not in how you feel right now — it is in what can happen to the pump if the blood forms a clot inside it. When that happens, the first signs are visible to us in the pump data, before you feel anything. If we wait until you feel bad, it is already harder to treat. The INR of 2.7 you had last time kept the blood thin enough for the pump to function without problems. The 1.7 today is not enough. We need to adjust the dose today.)

What does life with an LVAD look like for a Spanish-speaking patient, and what must she know before surgery?

Before agreeing to LVAD implantation, a Spanish-speaking patient needs a clear picture of the daily life changes the device requires, because the device is not just a surgical procedure — it is a commitment to a set of daily management tasks that must be performed correctly for the rest of the time on support. The key elements are: the driveline, the controller, the batteries, water safety, the emergency protocol, and the INR. The driveline exits the skin through an abdominal wound. The exit site must be cleaned and dressed daily using sterile technique and the specific supplies provided by the LVAD program. The driveline must be immobilized — secured to the body with a stabilization vest or belt — because movement of the driveline at the exit site causes mechanical trauma that disrupts the skin-cable seal, opening the path to infection. The controller is a small external computer that runs the pump. It is worn continuously and monitors pump function, speed, power consumption, and flow. Alarms — audible beeps and lights — indicate specific problems. The patient and at least one caregiver must know what each alarm means and what to do for each. The batteries power the controller and pump. Two batteries are worn at all times; they must be charged regularly; backup batteries must be kept available; a power module that plugs into a wall outlet is used during sleep. Running out of power means the pump stops. The patient must shower with a waterproof cover over the controller and exit site — the pump and controller cannot be submerged. Swimming and tub baths are prohibited for the duration of LVAD support. Emergencies: the patient and one designated caregiver must be able to respond to a white screen alarm on the controller, which indicates a pump-stop or critical failure, and must call 911 immediately. For the bridge-to-transplant patient: the device is the bridge — it maintains the circulation while waiting for a donor heart. Staying on the transplant list requires continued eligibility, which includes clinic visits, compliance with medications and INR monitoring, and keeping the driveline site healthy. In Spanish: “La bomba le va a dar la estabilidad que el corazón no puede darle solo — eso es lo que le va a permitir esperar el trasplante. Pero la bomba necesita cuidado todos los días: la cura del cable, las baterías cargadas, el control del INR. Estas cosas no son opcionales — son parte del tratamiento igual que los medicamentos. Le vamos a enseñar todo antes de que salga del hospital, y vamos a practicar hasta que se sienta segura.” (The pump will give you the stability the heart cannot give you alone — that is what will allow you to wait for the transplant. But the pump needs care every day: the cable dressing, the charged batteries, the INR monitoring. These things are not optional — they are part of the treatment just like the medications. We are going to teach you everything before you leave the hospital, and we are going to practice until you feel confident.)

What are the most important Spanish phrases for LVAD nurses working with Spanish-speaking patients?

The most important Spanish phrases for LVAD nurses address the three communication gaps that determine whether the patient stays safe outside the hospital: the bridge-to-transplant explanation, the driveline infection emergency response, and the INR adherence rationale. For the bridge-to-transplant explanation: “El corazón todavía late, pero no está produciendo suficiente flujo para los órganos. La bomba va a hacer esa parte del trabajo mientras espera el trasplante.” (The heart is still beating, but it is not producing enough flow for the organs. The pump is going to do that part of the work while you wait for the transplant.) For the ejection fraction: “La fracción de eyección es el porcentaje de sangre que el corazón saca con cada latido. Lo normal es 55 a 70. El suyo está en 15 — eso significa que el 85 por ciento de la sangre se está quedando adentro con cada latido.” (The ejection fraction is the percentage of blood the heart pumps out with each beat. Normal is 55 to 70. Yours is at 15 — that means 85 percent of the blood is staying inside with each beat.) For driveline redness: “Si el sitio donde sale el cable se pone rojo, caliente o le empieza a salir algo — llame a la clínica el mismo día. No espere a ver si se quita solo. No ponga ninguna crema sin hablarnos.” (If the spot where the cable exits turns red, warm, or starts draining something — call the clinic the same day. Do not wait to see if it goes away on its own. Do not apply any cream without talking to us.) For driveline immobilization: “El cable tiene que estar asegurado al cuerpo todo el tiempo. Si se mueve mucho en la piel, abre la entrada a infección. El cinturón o chaleco de sujeción no es opcional — es parte del cuidado.” (The cable must be secured to the body at all times. If it moves too much against the skin, it opens the path to infection. The stabilization belt or vest is not optional — it is part of the care.) For INR: “El INR mide qué tan fluida está la sangre. La bomba necesita que la sangre esté entre 2.0 y 3.0 para no formar coágulos adentro. Si baja de ese rango, el riesgo es que la bomba deje de funcionar — y eso es una emergencia.” (The INR measures how thin the blood is. The pump needs the blood to be between 2.0 and 3.0 to prevent clots from forming inside. If it drops below that range, the risk is that the pump stops working — and that is an emergency.) For pump alarms: “Si la pantalla del controlador se pone completamente blanca o escucha una alarma que no conoce, llame al 911 inmediatamente y diga: tengo un dispositivo de asistencia ventricular izquierda.” (If the controller screen turns completely white or you hear an alarm you do not recognize, call 911 immediately and say: I have a left ventricular assist device.) For batteries: “Las baterías nunca deben llegar a cero. Cambie la batería cuando el controlador avise que queda el 25 por ciento. Siempre tenga baterías de repuesto cargadas en la casa.” (The batteries must never reach zero. Change the battery when the controller alerts that 25 percent remains. Always have charged spare batteries at home.)

Clinical Spanish July 30, 2026

Spanish for LVAD nurses — the patient offered a mechanical heart pump who cannot understand why she needs it when she already has a heart, the patient whose driveline exit site has been red for three days and who applied Neosporin, and the patient whose warfarin INR is 1.7 and who feels completely fine

Three LVAD conversations in Spanish: explaining why a beating heart at 15% ejection fraction is not enough; managing the call from a patient who self-treated a driveline site infection for three days; and counseling the patient who feels well but whose subtherapeutic INR puts the pump at risk of thrombosis.

Why these three conversations

Rosa García is 58 years old. She was a schoolteacher in San Jose for thirty-one years. She retired two years ago and spent the first year doing the things she had deferred: cooking, garden, daily walks with her sister. Six months ago the walks got harder. Three months ago she stopped making it to the corner without stopping. Last week she was admitted to the cardiac ICU with a pulmonary capillary wedge pressure of 36 mmHg, an ejection fraction of 15%, and a creatinine that had climbed from her baseline of 0.9 to 2.4 in six days. The cardiologist has recommended an LVAD as bridge to cardiac transplant.

Rosa listens to the explanation. Then she asks LVAD coordinator nurse Alejandra López: “¿Pero mi corazón todavía late. Por qué necesito una bomba si el corazón todavía está trabajando?”

Carlos Mendoza is 47. He is a construction supervisor from Phoenix who had an LVAD implanted eight months ago for ischemic cardiomyopathy and is listed for cardiac transplant. He is excellent at showing up for clinic appointments. He is less good at calling between appointments when something worries him. He has spent the last three days applying Neosporin to his driveline exit site because it looked a little red and he did not want to call the clinic for something that might be nothing.

He calls this morning because the site is now clearly swollen and there is a small amount of yellowish discharge. He says: “No quería llamar por algo pequeño. Pensé que se iba a quitar solo.”

Elena Fuentes is 62. She retired from the US Postal Service and lives in Miami with her husband of thirty-eight years. She had an LVAD implanted nine months ago for non-ischemic dilated cardiomyopathy and is on the transplant waitlist. She has been taking warfarin since before discharge and understands that her target is “between two and three.” Her INR result today is 1.7. LVAD clinic nurse Patricia Vargas calls to discuss the result.

Elena: “Me siento igual que siempre. La semana pasada me sentía bien, hoy me siento bien. ¿Por qué importa tanto ese número si la bomba tiene su propio motor?”

Each of these conversations has the same underlying structure: the patient cannot see or feel the danger, and the nurse must make the invisible risk concrete enough to change behavior before something irreversible happens.

Scenario 1 — Rosa García, 58, retired schoolteacher from San Jose, EF 15%, bridge to transplant, asking LVAD coordinator nurse Alejandra López why she needs a mechanical pump when her heart is still beating

Alejandra sits down across from Rosa in the family room adjacent to the cardiac ICU. Rosa’s daughter, Valeria, 34, is seated next to her. Alejandra has brought a laminated diagram of the heart and LVAD system.

Rosa: “¿Pero el corazón todavía late, no? Yo lo siento. ¿Para qué necesito una bomba si el corazón todavía está trabajando?”

(But the heart is still beating, right? I feel it. Why do I need a pump if the heart is still working?)

Alejandra: “Sí, late. Eso es lo que quiero explicarle — porque esa pregunta tiene una respuesta muy concreta. No es que el corazón parace no funcionar. Es que no está produciendo suficiente flujo con cada latido.”

(Yes, it is beating. That is what I want to explain to you — because that question has a very concrete answer. It is not that the heart has stopped working. It is that it is not producing enough flow with each beat.)

What the ejection fraction means

Alejandra explains the ejection fraction in terms Rosa can use as a framework. The left ventricle — the main pumping chamber — fills with blood between beats and then contracts to push that blood out into the aorta and onward to the body. The ejection fraction is the percentage of the blood in the left ventricle that actually gets pushed out with each contraction.

A normal left ventricle ejects 55 to 70 percent of its blood volume with each beat. That means for every 100 milliliters filling the chamber, 55 to 70 leave into the aorta. The heart does this 60 to 100 times per minute, generating a cardiac output of four to eight liters per minute at rest, more with activity.

Rosa’s ejection fraction is 15 percent.

Alejandra: “Con cada latido, su corazón está sacando solo el 15 por ciento de la sangre que tiene adentro. Los otros 85 por ciento — 85 de cada 100 — se queda adentro. El corazón late, sí, pero cada latido produce muy poco flujo.”

(With each beat, your heart is pushing out only 15 percent of the blood inside it. The other 85 percent — 85 out of every 100 — stays inside. The heart beats, yes, but each beat produces very little flow.)

Rosa: “¿Y eso es lo que está en los pulmones?”

(And that is what is in the lungs?)

Alejandra: “Exactamente. La sangre que no sale del ventrículo sube la presión hacia atrás: al atrío izquierdo, a las venas de los pulmones, a los capilares pulmonares. Cuando esa presión sube demasiado, el líquido sale de los capilares y entra a los alveolos — a los sacos de aire. Eso es el edema pulmonar. Por eso le faltó el aire. Y al mismo tiempo, lo que sí sale hacia adelante no es suficiente para los riñones, el hígado y los músculos. Por eso subió la creatinina.”

(Exactly. The blood that does not leave the ventricle raises pressure backward: to the left atrium, to the pulmonary veins, to the pulmonary capillaries. When that pressure rises too high, fluid exits the capillaries and enters the alveoli — the air sacs. That is pulmonary edema. That is why you got short of breath. And at the same time, what does go forward is not enough for the kidneys, the liver, and the muscles. That is why the creatinine rose.)

What the LVAD does

The left ventricular assist device that Rosa’s team is recommending is a HeartMate 3: a centrifugal continuous-flow pump, about the size of a large tangerine, that sits inside the chest adjacent to the left ventricle. Two cannulas connect the pump to the circulation. The inflow cannula enters through the apex — the tip — of the left ventricle: it sits inside the ventricle and actively draws blood out. The outflow cannula delivers that blood to the ascending aorta, just above the aortic valve.

A percutaneous cable — the driveline — exits the skin in the right upper abdominal wall and connects the internal pump to an external system: a small controller worn on the body, and two lithium-ion batteries that power the pump. The pump runs continuously, spinning at 2,400 to 3,200 rotations per minute, generating a steady, non-pulsatile flow of four to six liters per minute regardless of what the native heart contributes.

Alejandra: “La bomba entra por la punta del ventrículo. Saca la sangre directamente de adentro y la lleva a la aorta. El ventrículo, que estaba lleno y bajo presión, empieza a vaciarse. La presión que estaba empujando hacia atrá hacia los pulmones baja. Los pulmones mejoran. Y al mismo tiempo, el flujo que llega al resto del cuerpo aumenta. Los riñones vuelven a recibir lo que necesitan.”

(The pump enters through the tip of the ventricle. It pulls blood directly from inside and delivers it to the aorta. The ventricle, which was full and under pressure, begins to empty. The pressure that was pushing backward toward the lungs drops. The lungs improve. And at the same time, the flow reaching the rest of the body increases. The kidneys start receiving what they need.)

Rosa: “¿Y el corazón sigue latiendo?”

(And the heart keeps beating?)

Alejandra: “Sí. El corazón sigue latiendo y contribuye lo que puede. La bomba hace el resto. No reemplaza el corazón — trabaja junto con él. El corazón manda, la bomba apoya.”

(Yes. The heart keeps beating and contributes what it can. The pump does the rest. It does not replace the heart — it works together with it. The heart leads, the pump supports.)

The bridge and what it means

The medical team is recommending the LVAD as bridge to transplant. Rosa is a transplant candidate: her age, comorbidity profile, and absence of other organ failure make her eligible. The LVAD will support her circulation while she waits for a compatible donor heart.

For some patients the bridge is months. For others it is longer. During that time, the LVAD keeps the organs perfused, allows the kidneys and liver to recover from the low-output state, and often allows the patient to return home, resume activity, and improve nutritional status and physical conditioning in preparation for transplant surgery. Some patients on LVAD support improve enough that their UNOS listing status and urgency scores reflect a patient in much better condition than the one who was admitted to the cardiac ICU.

Alejandra: “El dispositivo es el puente. Le da la estabilidad que el corazón no puede darle ahora mismo para esperar el trasplante. No sabemos cuánto tiempo va a esperar — eso depende de los donantes disponibles y del emparejamiento. Pero durante ese tiempo, la bomba es la que la va a mantener en las condiciones para recibir el trasplante cuando llegue.”

(The device is the bridge. It gives you the stability the heart cannot give you right now so you can wait for the transplant. We do not know how long you will wait — that depends on available donors and matching. But during that time, the pump is what will keep you in the condition to receive the transplant when it comes.)

What daily life looks like

Alejandra explains the daily reality of LVAD life before Rosa makes a decision. This is not optional information — informed consent requires that the patient understand the commitments, not just the clinical benefits.

The driveline exits the skin permanently for the duration of LVAD support. The exit site must be cleaned and dressed daily using the supplies and technique the LVAD team will teach before discharge. The driveline must be secured to the body with a stabilization vest or belt at all times; movement of the cable at the exit site disrupts the skin seal and is the primary cause of driveline infection. Showering requires a waterproof cover over the controller and exit site. Bathing in a tub and swimming are not permitted.

The controller — a small external device worn on a harness or belt — monitors the pump continuously. It will alarm if there are changes in pump function. The patient and at least one caregiver must learn what each alarm means and how to respond. Two batteries power the controller and pump; they must be swapped before depleting and kept charged. A wall-powered module is used during sleep. Spare charged batteries must be kept accessible at all times. A white-screen alarm on the controller indicates a critical failure and requires immediate 911 activation.

Alejandra: “Le vamos a enseñar todo esto antes de que salga del hospital. Vamos a practicar el cuidado del cable, el cambio de baterías, y qué hacer con cada alarma hasta que usted y la persona que le ayuda en casa se sientan seguros. No se va a ir a casa hasta que estemos seguros juntos.”

(We are going to teach you all of this before you leave the hospital. We are going to practice the cable care, the battery change, and what to do with each alarm until you and the person helping you at home feel confident. You are not going home until we are confident together.)

Rosa nods and looks at her daughter. Valeria takes her hand.

Rosa: “¿Y después del trasplante se quita todo esto?”

(And after the transplant all of this is removed?)

Alejandra: “Sí. El trasplante es el objetivo. La bomba es lo que la lleva hasta ahí.”

(Yes. The transplant is the goal. The pump is what takes you there.)

Scenario 2 — Carlos Mendoza, 47, construction supervisor from Phoenix, eight months post-LVAD, calling about a driveline exit site that has been red for three days

Carlos calls at 9:14 a.m. LVAD coordinator nurse Isabel Ramos answers.

Carlos: “Mire, no quería llamar por algo pequeño. Hace tres días que el lugar donde sale el cable se ve un poco rojo. Le puse Neosporín porque pensé que era una irritación de la piel. Pero esta mañana está un poco hinchado y está saliendo algo amarillo.”

(Look, I did not want to call for something small. For three days the place where the cable exits has looked a little red. I applied Neosporin because I thought it was a skin irritation. But this morning it is a little swollen and something yellow is coming out.)

Isabel: “Carlos, gracias por llamar. Necesito que venga a la clínica hoy — esta mañana si puede. Lo que me describe necesita que lo veamos en persona hoy. ¿Puede llegar antes del mediodía?”

(Carlos, thank you for calling. I need you to come to the clinic today — this morning if you can. What you are describing needs us to see it in person today. Can you get here before noon?)

Carlos: “¿Es serio?”

(Is it serious?)

Isabel: “Puede serlo. Por eso necesito verlo hoy. Voy a explicarle por qué mientras viene.”

(It can be. That is why I need to see it today. I am going to explain why while you are on your way.)

The anatomy of the driveline: why infection is not a local problem

Isabel explains the anatomical reality of the driveline while Carlos arranges a ride to the clinic. The explanation is essential because Carlos has framed this as a skin irritation — something local, manageable, likely to resolve on its own. The nurse must replace that frame with the accurate one before he arrives, both to ensure he actually comes and to prepare him for the evaluation and likely treatment.

The driveline is a braided cable that enters the skin in the abdominal wall, passes through the subcutaneous tissue, traverses the anterior abdominal fascia, and extends through the mediastinum to the pump sitting against the left ventricle. The cable creates a permanent percutaneous pathway — a direct anatomical connection between the skin surface and the mediastinal space. This pathway exists as long as the LVAD is in place.

A healthy driveline exit site is one where the skin has formed a tight seal around the cable, the cable is immobilized to prevent mechanical disruption of that seal, and the local tissue shows no signs of infection. Daily exit site care — cleaning with chlorhexidine, applying clean dressings, securing the cable — maintains this seal.

When bacteria colonize the exit site — from the patient’s own skin flora, from contact contamination, from a breach in dressing technique — the infection does not stay local. It has a path. Superficial exit site infection: limited to the skin at the surface. Deep exit site infection: involving the subcutaneous tissue around the cable. Driveline tunnel infection: ascending along the cable through the subcutaneous tissue. Device pocket infection: reaching the space where the pump housing sits. Mediastinitis: infection of the mediastinal space. Bacteremia and endocarditis: seeding of the bloodstream and the pump and its connections.

Each stage is harder to treat than the one before it. Superficial infection caught on day one requires topical care and oral antibiotics. Driveline tunnel infection requires intravenous antibiotics and surgical debridement. Mediastinitis with device involvement may require device exchange — a redo cardiac surgery in an already critically ill patient — or urgent transplant as the only option.

Isabel: “El cable no está nada más en la piel. Pasa por debajo de la piel, por la múscula de la barriga, y llega hasta el pecho donde está la bomba. Cuando la infección empieza en la piel — como lo que usted tiene ahora — tiene un camino físico para subir. Si no la tratamos rápido, puede llegar a donde está la bomba. Y eso es una complicación muy seria que es muy difícil de tratar.”

(The cable is not only in the skin. It passes under the skin, through the abdominal muscle, and reaches the chest where the pump is. When the infection starts in the skin — like what you have now — it has a physical path to travel upward. If we do not treat it quickly, it can reach where the pump is. And that is a very serious complication that is very difficult to treat.)

Carlos: “Pensé que era como una roncha.”

(I thought it was like a rash.)

Isabel: “Lo entiendo. En cualquier otra persona, eso podría ser cierto. Pero con el cable, no hay infección pequeña. Cualquier señal en ese sitio es urgente.”

(I understand. In any other person, that might be true. But with the cable, there is no small infection. Any sign at that site is urgent.)

Why Neosporin was the wrong choice

Isabel addresses this directly and without blame, because the next patient who does the same thing needs to understand the reasoning, not just be told it was wrong.

Triple antibiotic ointment — neomycin, polymyxin B, bacitracin (sold as Neosporin) — is a reasonable first response for superficial skin abrasions in people without devices. At the LVAD driveline exit site, it is specifically contraindicated in most LVAD programs for several reasons.

First, neomycin is one of the most common causes of contact dermatitis and skin sensitization. Applied repeatedly to an already-compromised exit site, it can cause an allergic skin reaction that looks identical to a worsening infection, delays accurate diagnosis, and further compromises the skin barrier. Second, unsupervised topical antibiotic application alters the local skin flora. A healthy exit site has a skin flora that, when managed with the prescribed chlorhexidine dressing routine, remains controlled. Introducing a broad-spectrum topical antibiotic without culture guidance selects for resistant organisms — particularly Staphylococcus aureus, the most common LVAD driveline pathogen, and Pseudomonas aeruginosa, which is associated with deep driveline infections. Third, and most critically, the antibiotic ointment masks the clinical picture: it reduces superficial redness and weeping, giving both the patient and the examiner the impression that improvement is occurring, while infection ascends along the cable undetected.

Three days of Neosporin application is three days during which the infection was progressing without evaluation.

Isabel: “La Neosporín en la piel normal a veces ayuda. En el sitio del cable, el problema es que puede esconder lo que está pasando adentro y puede cambiar las bacterias que hay ahí de una manera que lo hace más difícil de tratar. Por eso en la hoja de instrucciones dice que no ponga ninguna crema o antíbiótico sin llamarnos primero. No es por capricho — es porque en ese sitio específico, lo que parece ayudar puede dañar.”

(Neosporin on normal skin sometimes helps. At the cable site, the problem is that it can hide what is happening inside and can change the bacteria there in a way that makes it harder to treat. That is why the instruction sheet says not to apply any cream or antibiotic without calling us first. It is not arbitrary — it is because at that specific site, what seems to help can harm.)

What the clinic visit will involve

Isabel prepares Carlos for the evaluation so the visit does not feel like a series of unexpected interventions.

The LVAD team will inspect the exit site visually and by palpation, assessing the depth of induration, whether the erythema extends along the driveline tunnel (tracking), and the nature of any drainage. A wound culture will be taken from the exit site. Blood cultures will be drawn to detect bacteremia. Blood tests including complete blood count, comprehensive metabolic panel, and C-reactive protein or erythrocyte sedimentation rate will assess the systemic inflammatory response. If there is concern for deep tissue involvement, cross-sectional imaging — CT of the chest and abdomen — may be ordered to assess the cable tunnel and device pocket.

Based on the findings, treatment will range from intensified local wound care and oral antibiotics for a superficial infection to inpatient admission and intravenous antibiotics for deeper involvement. Carlos should plan for the possibility that he may not go home after this visit.

Isabel: “Cuando llegue, vamos a ver el sitio, hacer un cultivo, y sacar sangre. Dependiendo de lo que encontremos, puede que tenga que quedarse en el hospital para antíbióticos intravenosos. Sepa que eso es una posibilidad real. No lo digo para asustarlo — lo digo para que no le sorprenda si eso pasa.”

(When you arrive, we are going to look at the site, take a culture, and draw blood. Depending on what we find, you may need to stay in the hospital for intravenous antibiotics. Know that is a real possibility. I am not saying it to frighten you — I am saying it so it does not surprise you if that happens.)

The rule for every future sign at the exit site

Before ending the call, Isabel states the rule clearly and explicitly, in terms that are easy to repeat to a family member.

Isabel: “Carlos, de hoy en adelante: cualquier cosa que note diferente en el sitio del cable — rojo, caliente, hinchado, húmedo, con pus, o simplemente que no se ve como siempre — llame a la clínica el mismo día. No espere a ver si se quita. No ponga nada. Llame. Tenemos turno de urgencias para esto. No es molestar — para eso estamos.”

(Carlos, from today forward: anything you notice different at the cable site — red, warm, swollen, wet, pus, or simply that it does not look the way it always does — call the clinic the same day. Do not wait to see if it goes away. Do not apply anything. Call. We have urgent appointments for this. It is not bothering us — this is what we are here for.)

Carlos arrives at the clinic at 11:40 a.m. The exit site has a 1.5 cm zone of erythema with induration and 0.3 mL of purulent drainage. Tracking is absent. The culture grows methicillin-sensitive Staphylococcus aureus. He is admitted for 48 hours of intravenous oxacillin, transitioned to oral dicloxacillin, and discharged with daily exit site care and a seven-day wound check appointment. The infection resolves fully at three weeks.

The attending LVAD coordinator adds a note to his file: day-one call would likely have been managed outpatient. Three-day delay required admission.

Scenario 3 — Elena Fuentes, 62, retired postal worker from Miami, INR 1.7, feeling completely well, asking LVAD clinic nurse Patricia Vargas why the number matters when the device has its own pump

Patricia calls Elena at 10:28 a.m. with her INR result from the morning draw. Elena’s target INR for LVAD anticoagulation is 2.0 to 3.0. Today’s result is 1.7.

Patricia: “Buenos días Elena, soy Patricia de la clínica del LVAD. Acabo de ver su INR de hoy — está en 1.7. Necesito hablar con usted sobre el resultado y ajustar la dosis de warfarina.”

(Good morning Elena, this is Patricia from the LVAD clinic. I just saw your INR from this morning — it is 1.7. I need to talk with you about the result and adjust the warfarin dose.)

Elena: “Me siento igual que siempre. Me sentía bien la semana pasada, hoy me siento bien. ¿Por qué importa tanto ese número si la bomba tiene su propio motor?”

(I feel the same as always. I felt fine last week, I feel fine today. Why does that number matter so much if the pump has its own motor?)

Why continuous-flow LVADs require anticoagulation

Patricia answers the question directly, beginning with why the pump’s own motor is exactly the reason anticoagulation is necessary.

A continuous-flow LVAD works by spinning a rotor at 2,400 to 3,200 rotations per minute inside the pump housing. Blood enters through the inflow cannula from the left ventricle, passes through the spinning rotor, and exits through the outflow cannula into the aorta. The flow is continuous — unlike the pulsatile flow the native heart generates with each beat, the LVAD generates a steady, non-pulsatile stream. The HeartMate 3 creates an artificial pulse by modulating rotor speed to produce a pulsatile waveform every two seconds, but the baseline flow between pulses is still continuous and non-pulsatile.

This non-pulsatile continuous flow has a consequence for coagulation. Human blood clotting is partly controlled by the mechanical forces of normal pulsatile flow: the periodic velocity changes and shear forces of a beating heart contribute to the washout of clotting factors and platelets from the surfaces of heart valves and vessel walls. Continuous-flow devices alter these dynamics. The pump housing, the inflow and outflow cannulas, and the graft anastomoses are prosthetic surfaces — foreign material to which platelets adhere and on which clotting cascades can be triggered. The non-pulsatile flow creates zones of relative stasis at specific locations within the circuit, particularly at the aortic valve (which may remain closed during LVAD support if the native ventricle contributes little forward flow) and at the anastomotic junction between the outflow graft and the aorta.

Patricia: “La bomba gira sin parar, sí. Pero el hecho de que gire sin parar es exactamente lo que crea el problema. Cuando la sangre fluye de manera continua por materiales artificiales dentro del pecho, hay lugares donde puede empezar a cuajarse. El INR entre 2 y 3 es lo que mantiene la sangre lo suficientemente fluida para que eso no pase. Cuando el INR baja a 1.7, la sangre está más espesa de lo que la bomba necesita.”

(The pump spins without stopping, yes. But the fact that it spins without stopping is exactly what creates the problem. When blood flows continuously through artificial materials inside the chest, there are places where it can start to clot. The INR between 2 and 3 is what keeps the blood thin enough for that not to happen. When the INR drops to 1.7, the blood is thicker than the pump needs it to be.)

What pump thrombosis is and why it happens without symptoms first

Elena’s question — why does the number matter if she feels fine — goes to the heart of the communication challenge. The danger of subtherapeutic anticoagulation in an LVAD patient is not immediate or symptomatic in its early stages. It is a slow accumulation of clot on the prosthetic surface of the pump, visible to the clinical team through indirect markers long before the patient notices any change in how she feels.

Pump thrombosis is the formation of thrombus within the pump housing, on the rotor, or at the inflow or outflow cannula junctions. As the thrombus grows, several things happen. The pump must work harder to generate the same flow against increased resistance within the housing. This increased workload is visible as rising power consumption — the controller records power in watts, and a sustained increase of 1 watt or more above baseline is a recognized early marker of pump thrombosis. The harder-working pump generates more mechanical trauma to red blood cells passing through it: hemolysis rises. Plasma-free hemoglobin increases. Lactate dehydrogenase — an enzyme released by lysed red blood cells — rises in the blood. The LDH level is routinely monitored at LVAD clinic visits precisely because it is one of the earliest detectable markers of pump thrombosis, often rising weeks before the patient notices any change in exercise tolerance or dyspnea.

The pulsatility index — a measurement of the variability in flow generated by the LVAD in response to the native heart’s contributions — changes as pump function is compromised. Flow alarms appear on the controller display. These signals collectively constitute an early warning system that the LVAD team monitors. The patient, feeling fine, is not aware of any of this until the thrombus is large enough to significantly compromise pump flow — at which point the heart failure symptoms that were suppressed by the device begin to return: returning dyspnea, reduced exercise tolerance, orthopnea.

By that point, the thrombus is established. Treatment options are limited: medical thrombolysis with intravenous tissue plasminogen activator carries a significant bleeding risk and is not always successful in dissolving an organized pump thrombus. Surgical pump exchange — replacing the thrombosed device with a new LVAD — requires redo cardiac surgery in a patient with advanced heart failure and carries substantial operative mortality. The worst-case scenario is complete pump failure before intervention is possible: cardiogenic shock.

Patricia: “Usted no siente nada porque la bomba todavía está funcionando. Pero cuando hay un coágulo formándose adentro, lo primero que vemos somos nosotros — en la presión que necesita la bomba para girar, en una enzima del hígado que sube cuando la bomba trabaja más duro, en las alarmas del controlador. Usted no siente eso. Nosotros lo vemos en los datos. Si esperamos a que usted sienta que está peor, el coágulo ya está establecido y es mucho más difícil sacarlo.”

(You do not feel anything because the pump is still working. But when there is a clot forming inside, the first ones to see it are us — in the pressure the pump needs to spin, in a liver enzyme that rises when the pump is working harder, in the controller alarms. You do not feel that. We see it in the data. If we wait until you feel worse, the clot is already established and much harder to remove.)

Elena: “¿Tan rápido puede pasar eso con un número de 1.7?”

(Can that happen so quickly with a number of 1.7?)

Patricia: “El 1.7 no es un número del que yo pueda decirle: tiene tres semanas para subirlo antes de que pase algo. No funciona así. El riesgo está activo desde el momento en que está por debajo de 2.0. Puede que nada pase en una semana. Puede que algo empiece a formarse en días. No sabemos cuándo — por eso el objetivo es que nunca baje de ese rango.”

(The 1.7 is not a number about which I can tell you: you have three weeks to bring it up before something happens. It does not work that way. The risk is active from the moment it is below 2.0. Maybe nothing happens in a week. Maybe something starts forming in days. We do not know when — that is why the goal is that it never drops below that range.)

Investigating why the INR dropped

A subtherapeutic INR in a patient who reports taking her warfarin consistently requires an investigation of what changed. Patricia reviews the differential with Elena.

Warfarin is metabolized by the cytochrome P450 2C9 enzyme in the liver. Many factors alter this metabolism and the resulting anticoagulation effect: changes in vitamin K intake (green leafy vegetables — spinach, kale, broccoli — are the most common dietary factor, and a sudden increase in consumption reduces INR), changes in other medications (antibiotics, antifungals, and many other drugs interact with warfarin metabolism), illness with diarrhea or vomiting (affecting absorption), alcohol consumption (acute alcohol inhibits warfarin metabolism, raising INR; chronic alcohol induces the enzyme, lowering INR), and changes in liver function.

Patricia: “Quiero preguntarle sobre las últimas dos semanas. ¿Comió algo diferente? ¿Mucha ensalada o espinaca o brócoli? ¿Empezó algún medicamento nuevo, vitamina, o suplimento? ¿Tuvo vómito o diarrea?”

(I want to ask about the last two weeks. Did you eat anything different? A lot of salad or spinach or broccoli? Did you start any new medication, vitamin, or supplement? Did you have vomiting or diarrhea?)

Elena recalls that her daughter brought over a new batch of green smoothies two weeks ago — spinach and kale-based, one large glass daily. She has had one every morning. She did not think to mention it at the previous visit because it is food, not medication.

Patricia: “La espinaca y la col rizada tienen mucha vitamina K, que es la que contrarresta la warfarina. Una cantidad grande todos los días puede bajar el INR significativamente. No tiene que dejar de tomarlos — solo tiene que ser consistente en la cantidad y decirme cuando cambie algo en la dieta. Vamos a subir un poco la dosis de warfarina para compensar.”

(Spinach and kale have a lot of vitamin K, which is what counteracts warfarin. A large amount every day can drop the INR significantly. You do not have to stop taking them — you just need to be consistent in the amount and tell me when anything in your diet changes. We are going to increase the warfarin dose a little to compensate.)

The rule Elena takes away from this call

Patricia closes with the three rules that apply to every LVAD patient on warfarin, stated simply enough to remember without a handout.

Patricia: “Tres cosas para recordar. Primero: el INR entre 2 y 3 no es negociable — es lo que protege la bomba. Segundo: cualquier cambio en la dieta, especialmente los vegetales verdes, cúenteme. No tiene que dejarlos de comer — solo consistencia y comunicación. Tercero: si alguna vez nota que la bomba suena diferente, que las alarmas cambian, o que empieza a sentir el aire corto otra vez, llame inmediatamente. No espere a la próxima cita.”

(Three things to remember. First: the INR between 2 and 3 is not negotiable — it is what protects the pump. Second: any change in diet, especially green vegetables, tell me. You do not have to stop eating them — just consistency and communication. Third: if you ever notice the pump sounds different, the alarms change, or you start feeling short of breath again, call immediately. Do not wait for the next appointment.)

Elena: “Entonces los jugos de espinaca sí los puedo seguir tomando si los tomo igual todos los días.”

(So I can keep taking the spinach juices if I have them the same way every day.)

Patricia: “Exactamente. La consistencia es lo que nos da la estabilidad del INR. Un cambio grande en la cantidad es lo que lo sube o lo baja.”

(Exactly. Consistency is what gives us INR stability. A large change in amount is what raises or lowers it.)

Elena’s warfarin dose is increased. Her INR at the next check, eleven days later, is 2.4.

Eight practical phrases for LVAD nurses

The three scenarios above illustrate the communication failures that produce the worst outcomes in LVAD nursing: the patient who refuses a device she does not understand; the patient who waits three days to report a driveline infection; the patient who ignores a subtherapeutic INR because she feels fine. The phrases below are the clinical Spanish framework that prevents each failure.

Ejection fraction explanation: “La fracción de eyección de 15 significa que el corazón saca solo el 15 por ciento de la sangre con cada latido. El 85 por ciento que se queda sube la presión hacia los pulmones y le quita flujo a los riñones. La bomba quita esa sangre que el corazón no puede quitar solo.” (An ejection fraction of 15 means the heart pushes out only 15 percent of the blood with each beat. The 85 percent that stays raises pressure toward the lungs and takes flow away from the kidneys. The pump removes the blood the heart cannot remove alone.)
Bridge to transplant framing: “La bomba es el puente. Mantiene los órganos funcionando mientras esperamos un corazón donado. El trasplante sigue siendo el objetivo.” (The pump is the bridge. It keeps the organs functioning while we wait for a donor heart. The transplant is still the goal.)
Driveline infection urgency rule: “Cualquier cosa diferente en el sitio del cable — rojo, caliente, hinchado, mojado, o pus — llame el mismo día. No hay infección pequeña en ese sitio porque el cable va directo al pecho.” (Anything different at the cable site — red, warm, swollen, wet, or pus — call the same day. There is no small infection at that site because the cable goes directly into the chest.)
No self-treatment at the exit site: “No ponga ninguna crema, antíbiótico, o remedios caseros en el sitio del cable sin hablarnos primero. Eso incluye Neosporín.” (Do not apply any cream, antibiotic, or home remedies at the cable site without talking to us first. That includes Neosporin.)
Driveline immobilization: “El cable tiene que estar sujeto al cuerpo todo el tiempo. Si se mueve en la piel, abre la entrada a infección. El cinturón o chaleco de sujeción no es opcional.” (The cable must be secured to the body at all times. If it moves against the skin, it opens the path to infection. The stabilization belt or vest is not optional.)
INR and pump thrombosis: “El INR protege la bomba por dentro. Cuando baja de 2.0, la sangre puede cuajarse adentro de la bomba antes de que usted sienta algo. Por eso actuamos hoy, no después.” (The INR protects the pump from inside. When it drops below 2.0, the blood can clot inside the pump before you feel anything. That is why we act today, not later.)
Diet and warfarin: “La vitamina K de los vegetales verdes baja el INR. No tiene que dejar de comerlos — tiene que ser constante en la cantidad y avisarme cuando cambie.” (Vitamin K from green vegetables lowers the INR. You do not have to stop eating them — you need to be consistent in the amount and tell me when it changes.)
White-screen alarm: “Si la pantalla del controlador se pone completamente blanca o escucha una alarma que no conoce, llame al 911 inmediatamente y diga: tengo un dispositivo de asistencia ventricular izquierda.” (If the controller screen turns completely white or you hear an alarm you do not recognize, call 911 immediately and say: I have a left ventricular assist device.)

What makes LVAD patient communication uniquely difficult

Each of the three scenarios in this post shares a structural feature that makes LVAD patient communication among the most demanding in advanced heart failure nursing: the danger is invisible to the patient, requires sustained daily vigilance to prevent, and produces catastrophic consequences when the vigilance lapses.

Rosa cannot feel the pulmonary hypertension that has been building for months, or understand why a beating heart is insufficient. The ejection fraction is a number she was given without the framework to interpret it. The LVAD nurse must provide that framework in a single conversation, at a moment when the patient is frightened and facing a surgical decision, in a second language.

Carlos knows his driveline exit site looked different. He made a reasonable inference — skin irritation, apply topical antibiotic, watch and wait — based on everything he knew about skin problems before he had an LVAD. That inference was wrong in his specific situation because the driveline creates an anatomical fact that ordinary skin care reasoning cannot account for. The LVAD nurse must rebuild the patient’s intuition about what constitutes a minor skin finding versus an urgent call, and that rebuilding must happen at discharge, not after the first complication.

Elena is not non-compliant. She takes her warfarin every day. She goes to her clinic appointments. She checks her INR. She simply does not have the framework that connects a number she cannot feel to a device she cannot see to a consequence she cannot predict. The LVAD nurse who gives her that framework — specifically, that the first evidence of pump thrombosis appears in device data before it appears in symptoms — changes the patient’s understanding of why INR monitoring is not a bureaucratic requirement but a clinical intervention in its own right.

All three require Spanish fluency that goes beyond vocabulary. They require the ability to construct a mechanistic explanation in clinical Spanish, calibrated to a patient who has no prior cardiac engineering knowledge, that is accurate enough to change behavior and honest enough to sustain trust across a multi-year clinical relationship.

For more clinical Spanish for advanced heart failure patients, see Spanish for heart failure clinic nurses, Spanish for heart failure clinic nurses (device therapy), Spanish for advanced heart failure clinic nurses, and Spanish for heart failure clinic nurses (transplant conversations). Practice these phrases with AI patients at ClinicaLingo practice, or download the 50 Spanish ED phrases PDF for quick-reference use on your shift.

The complete library of clinical-Spanish scenario posts is at the ClinicaLingo blog.